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BY-NC-ND license (http://creativecomAbstract Background: Vitamin D deficiency has been associated with systemic lupus erythe-
matosus (SLE), but there is no consensus on the role of serum vitamin D in evaluating or pre-
dicting disease activity. This study aimed to demonstrate the direct correlation between
vitamin D level and pediatric-onset SLE disease activity by a retrospective cohort study design.
Patients and methods: Thirty-five patients with pediatric-onset SLE and paired sera at the
active and inactive disease states were enrolled. Disease activity was defined by Systemic
Lupus Erythematosus Disease Activity Index 2000, and active lupus nephritis (LN) was defined
as active urine sediment, and proteinuria >2þ on stick or >500 mg/day. All data were re-
viewed and calculated from previous medical records. The levels of both vitamin D2 and
vitamin D3 were checked by electrochemiluminescence immunoassay.
Results: Serum 25-hydroxyvitamin D (25-OH D) levels in the active status were significantly
lower compared to that in inactive disease status (12.0  7.2 ng/mL vs. 15.4  7.4 ng/mL,
p Z 0.005). A subgroup analysis revealed that at active disease status, patients with LN had
lower 25-OH D levels than patients without LN (16.3  8.2 ng/mL vs. 9.8  5.6 ng/mL,
pZ 0.023). Moreover, there is a significant inverse correlation between serum 25-OH D levels
and Systemic Lupus Erythematosus Disease Activity Index 2000 at both inactive (r Z 0.335,
p Z 0.003) and active (r Z 0.373, p Z 0.016) disease status.
Conclusion: Serum vitamin D levels are inversely correlated with SLE disease activity at both
active and inactive disease status, and also with the presence of LN at active disease stage.llergy, Asthma and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, 5 Fu-
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WBC (103/mL) 5188  2175 4774  2181 0.242
Hemoglobin (g/dL) 12.5  1.1 11.4  2.1 0.458
Platelet (103/mL) 249.6  74.9 185.7  98.5 0.004
Creatinine (mg/dL) 0.55  0.11 0.61  0.23 <0.001
C3 (mg/dL) 77.7  23.0 59.7  23.0 0.005
C4 (mg/dL) 12.4  5.8 10.0  6.26 0.019
Anti-dsDNA (IU/mL) 178.3  145.6 261.7  180.6 <0.001
SLEDAI-2K 2.5  1.7 12.1  6.5 0.006Introduction
Vitamin D is a fat-soluble prohormone, and the vitamin D
endocrine system classically has an important role in
regulating calcium and bone homeostasis. Vitamin D is
resorbed from the skin and diet, and is metabolized in the
liver to 25-hydroxyvitamin D (25-OH D), which is the best
marker reflecting vitamin D status. The major active form
of vitamin D is 1,25-dihydroxyvitamin D. It is converted
from 25-OH D in the kidneys by the enzyme 25-
hydroxyvitamin D-1a-hydroxylase. The 1,25-
dihydroxyvitamin D acts on multiple targets through nu-
clear vitamin D receptors.1,2
Vitamin D deficiency is not an uncommon disorder. It
affects all age and ethnic groups, and it is even more
prevalent in children.3 Currently, there are growing data
regarding the association between vitamin D and immuno-
logic or autoimmune diseases.4e8
Systemic lupus erythematosus (SLE) is a complicated
autoimmune disease with multiple underlying immunologic
mechanisms; it commonly involves the kidney, causing
lupus nephritis (LN).9 Clinical studies on vitamin D and SLE
have been introduced since 1995.10 In SLE patients, the
prevalence of vitamin D deficiency ranges from 16% to
96%.11 Most reports have been designed as cross-sectional
studies with or without control groups. Despite the
diverse definitions, the prevalence of vitamin D deficiency
or insufficiency among SLE patients is higher than in healthy
groups. Several cross-sectional studies also reveal an in-
verse correlation between serum vitamin D level and SLE
disease activity, reinforcing the importance of vitamin D in
SLE and the immune system.12e19
A significant number of SLE studies have been conducted
over the past few years, but there is still a paucity of
straight evidence of the relationship between vitamin D and
pediatric-onset SLE. This study aims at providing longitu-
dinal data to demonstrate the direct correlation between
vitamin D and pediatric-onset SLE.Daily steroid dose
(mg)
7.9  5.6 7.6  6.1 0.794
Cumulative steroid
dose (mg)
236.4  192.7 255.8  231.9 0.328
Data are presented as mean  SD and analyzed with paired
samples t test.
All study patients (nZ 35) had both active and inactive disease
status. Laboratory test results revealed WBC count, hemoglo-
bin, platelet, creatinine, complement C3 and C4, and anti-
dsDNA. The daily and cumulative steroid use of the patients
1 month before the examination was also included in the table.
All data were reviewed and calculated from previous medical
records.
Anti-dsDNAZ anti-double-strand DNA antibody; SDZ standard
deviation; SLEDAI-2K Z Systemic Lupus Erythematosus Disease
Activity Index 2000; WBC Z white blood cell.Methods
In this current study, children diagnosed with SLE with both
active and inactive disease status were enrolled. All de-
mographic data, clinical manifestations, laboratory values,
disease activity indices, and medications were reviewed
and calculated from previous medical records (Table 1).
Active disease was defined according to published defini-
tions20,21 and Systemic Lupus Erythematosus Disease Ac-
tivity Index 2000 (SLEDAI-2K).22 Active disease was defined
as SLEDAI-2K  5, while inactive disease was defined as
SLEDAI-2K  4. Active LN was present in 23 patients at
active disease status, and active LN was defined as active
urine sediment, and proteinuria >2þ on stick or >500 mg/n T-C, et al., Correlation between
caseecohort study, Journal of Mday. All patients were under regular outpatient department
follow up, and laboratory assessment was conducted every
1e3 months based on disease severity, for an average
follow-up duration of 6 years. All laboratory data were
rechecked on each visit. All patients had been receiving
continuous prednisolone-based treatment at both active
and inactive periods, and two complete data sets for each
patient were obtained at the active and inactive periods of
the disease.
Laboratory tests included complete blood count with
differential, creatinine, complement C3 and C4, and anti-
double-strand DNA antibody. Serum and plasma samples
were stored at 20C until further use and serum 25-OH D
concentrations were measured by an automated
electrochemiluminescence-based assay (Elecsys Vitamin D
total assay; Roche Diagnostics, Mannheim, Germany) ac-
cording to the manufacturer’s instructions. Vitamin D
deficiency was defined as <20 ng/mL and insufficiency as
<30 ng/mL, according to the published criteria.23
Data were analyzed by paired t test, ManneWhitney U
test, and one-way analysis of variance (SPSS Statistics
17.0.1; SPSS Inc., Chicago, United States) with a longitu-
dinal design and with paired sera. To correct the influencedisease activity of pediatric-onset systemic lupus erythematosus
icrobiology, Immunology and Infection (2016), http://dx.doi.org/
Figure 1. (A) Individual profile plots of 25-hydroxyvitamin D
(25-OH D) levels at active and inactive disease status. Paired t
test shows that the serum 25-OH D levels in active disease
status is significantly lower than that in inactive disease status
(12.0  7.2 ng/mL vs. 15.4  7.4 ng/mL, p Z 0.005). (B)
Percentage bar graph for changes of 25-OH D levels of indi-
vidual patients from inactive to active disease status. Of the
total 35 patients, 25 had lowered serum 25-OH D levels at
active disease status. The mean percentage change of serum
25-OH D levels from inactive disease status to active disease
status is 17.9% and the median percentage change is 30.8%.
25-OH D Z 25-hydroxyvitamin D.
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ultraviolet seasons, defined as the period from March to
October, were taken into consideration. The Institutional
Review Board of Chang Gung Medical Foundation approved
the study (IRB: 103-2832B).
Results
Thirty-five patients with pediatric-onset SLE and age of
onset under 18 years were included. The patient’s mean
age at disease onset of SLE was 12.9  3.12 years (range,
6e18 y). Patients who expired within 6 months from the
onset of disease and those who had mixed connective tissue
disorder or pre-existing major organ disease, such as irre-
versible renal failure, complex congenital heart disease, or
chromosome anomaly, were excluded from this study. All
patients went through both active and inactive disease
status and had constant follow up of laboratory data every
month (Table 1). Data of each patient were collected at
both active and inactive disease status.
Among the 35 patients at inactive disease stage, 33 (94%)
had vitamin insufficiency and 28 (80%) had vitamin D defi-
ciency. Moreover, individual profile plots showed that
compared to sera in the inactive disease status, sera in the
active disease status had significantly lower serum 25-OH D
levels (12.0  7.2 ng/mL vs. 15.4  7.4 ng/mL, p Z 0.005;
Figure 1A). The overall mean percentage change of serum
25-OH D levels of patients from inactive to active disease
status was 17.9%, with the median percentage change
being 30.8% (Figure 1B). A subgroup analysis also revealed
that patients with LN had lower 25-OH D levels than those
without LN during active disease status (16.3  8.2 ng/mL
vs. 9.8  5.6 ng/mL, p Z 0.023; Figure 2).
Simple linear regression was performed to demonstrate
the correlation between serum 25-OH D levels and SLEDAI-
2K scores. Serum 25-OH D levels in both inactive and active
disease status were significantly but inversely correlated
with SLEDAI-2K (r Z 0.335, p Z 0.003 and r Z 0.373,
p Z 0.016, respectively; Figures 3A and 3B). In addition,
univariate analysis demonstrated that serum 25-OHD status
was not significantly associated with the levels of white
blood cell (p Z 0.987), hemoglobin (p Z 0.428), platelet
(p Z 0.389), creatinine (p Z 0.775), or anti-double-strand
DNA antibody (p Z 0.243), or daily and cumulative steroid
dosages within 1 month before the examination (pZ 0.794
and pZ 0.328, respectively). There was also no correlation
between vitamin D levels and patients’ age, seasons in
which serum was taken, the presence of malar rash and
arthritis, or use of hydroxychloroquine.
Discussion
This study suggests that vitamin D deficiency and insuffi-
ciency are highly prevalent in children with SLE in Taiwan.
In a previous study by Yao et al,23 which included 1315
healthy individuals aged 10.3  2.7 years in Taiwan, the
prevalence of vitamin D insufficiency (25-OH D <30 ng/mL)
was as high as 90.3%, while that of vitamin D deficiency (25-
OH D <20 ng/mL) was 51.0%, and the mean concentration
of serum 25-OH D in healthy individuals was 20.4  7.1 ng/
mL. Our study shows that there is even higher prevalence ofPlease cite this article in press as: Lin T-C, et al., Correlation between
and level of vitamin D in Taiwan: A caseecohort study, Journal of M
10.1016/j.jmii.2015.12.005vitamin D deficiency in SLE patients, regardless of their
disease status (the mean concentration of 25-OH D:
15.4  7.4 ng/mL for inactive disease and 12.0  7.2 ng/mL
for active disease).
Additionally, this study also demonstrates that at active
disease status, LN can be a predictor of vitamin D defi-
ciency. Compared to the 25-OH D levels in the inactive
stage of SLE, the levels of 25-OH D in the active stage were
significantly lower. Interestingly, an inverse correlation
between SLEDAI-2K and serum 25-OH D levels is alsodisease activity of pediatric-onset systemic lupus erythematosus





Figure 2. Subgroup analysis of 25-hydroxyvitamin D (25-OH
D) levels in patients with and without lupus nephritis (LN) at
active disease status of systemic lupus erythematosus (SLE).
Two-tailed t test at 95% confidence level shows that patients
with LN (n Z 23) had lower 25-OH D levels than those without
LN (n Z 12) during active disease stage (16.3  8.2 ng/mL vs.







Figure 3. Plots of simple linear regression of 25-
hydroxyvitamin D (25-OH D) levels and Systemic Lupus Ery-
thematosus Disease Activity Index 2000 (SLEDAI-2K). (A) Serum
25-OH D levels were significantly but inversely correlated with
SLEDAI-2K in inactive disease status (r Z 0.335, p Z 0.003).
(B) A similar inverse correlation was observed in active disease
status (r Z 0.373, p Z 0.016). SLEDAI-2K Z Systemic Lupus
Erythematosus Disease Activity Index 2000; 25-OH D Z 25-
hydroxyvitamin D.
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icant at active disease status (rZ 0.373 vs. rZ 0.335).
This may be explained by the possible supporting role that
vitamin D has in the human immune system.24,25 It has been
suggested that immune cells such as macrophages, den-
dritic cells, B cells, and T cells that express the vitamin D
receptor can be enhanced by sufficient vitamin D supple-
ment.26 Furthermore, various autoimmune diseases have
been connected with vitamin D deficiency, including
asthma, arthritis, Hashimoto’s thyroiditis, and celiac dis-
ease. Thus, it will not be surprising if SLE also falls into this
category.27e29
Furthermore, a study published in 2013 observed a sta-
tistically significant improvement in urine protein-to-
creatinine ratio with higher levels of 25-OH D. This study
reported that a 20 ng/mL increase in vitamin D was asso-
ciated with a 21% decrease in the odds of having a high
activity score and a 15% decrease in the odds of having
clinically important proteinuria, but that there was no ev-
idence of additional benefit beyond a serum 25-OH D level
of 40 ng/mL.30 Although the population of this study was
adult SLE patients, we assume that an appropriate amount
of early vitamin D supplementation may also have an
immunomodulatory effect on pediatric SLE patients.
The limitations of this study include the high preva-
lence of vitamin D deficiency in Taiwan and the use of
corticosteroids in study participants. Although the influ-
ence of high-ultraviolet seasons was corrected, it remains
difficult to evaluate the possible effect that the habit of
sun avoidance has on each patient, which is quite
commonly seen in Asian countries including Taiwan.31e33
Moreover, the different disease durations of each indi-
vidual patient caused the intraindividual cumulative
corticosteroid doses over time to differ, thereby limiting
our ability to discern associations of vitamin D deficiency
and disease activity.Please cite this article in press as: Lin T-C, et al., Correlation between
and level of vitamin D in Taiwan: A caseecohort study, Journal of M
10.1016/j.jmii.2015.12.005In summary, this study shows that the serum 25-OH D
levels of SLE patients in Taiwan are inversely correlated
with SLEDAI-2K and that patients with LN have lower 25-OH
D levels than those without LN at active disease status.
These results indicate that among patients with SLE, LN
may be a predictor of vitamin D deficiency. It can also be
reasonably deduced from the above findings that vitamin D
deficiency may play a role in the physiologic consequencedisease activity of pediatric-onset systemic lupus erythematosus
icrobiology, Immunology and Infection (2016), http://dx.doi.org/
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+ MODELor the pathogenesis of SLE, and that it may be a potential
factor influencing disease flare-up.Conflicts of interest
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